Scholars Central

Conference abstractPublished 16 Feb 2019

The potential role of propolis on the therapeutic effectiveness of L-dopa during development of parkinsonism in rats

Authors: Azza A Ali

Al-Azhar University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Parkinson's disease (PD) is a geriatric neurodegenerative disorder where neuroinflammation and oxidative stress play a prominent role in the mechanisms underlying dopaminergic neurons degeneration. The immediate dopamine precursor L-dopa was the first efficient drug for PD treatment and remains the mainstay one, however long-term use is associated with motor fluctuations and dyskinesias. Propolis is one of the most important resinous natural product with wide range of biological activities as antiinflammatory and antioxidant, it has been demonstrated for prevention of geriatric neurodegenerations. Objective: To evaluate the efficacy of Propolis either alone or with L-dopa against rotenone-induced PD in rats and to investigate the possibility of using Propolis as an adjunct therapy for reducing L-dopa dosage without compromising its therapeutic outcome. Methods: Six groups of rats were used for 19 days; one normal group and five Rotenone (2.5 mg/kg SC) groups. One of the RT groups served as control PD model while the others treated with each of the following: L-dopa (10 or 25 mg/kg PO), Propolis (300 mg/kg PO) or both Propolis and L-dopa (10 mg/kg PO). Catalepsy, open-field and Y-maze tests were used for assessment of motor and cognitive performances. Striatal monoamines, acetylcholinesterase (AChE) as well as mitochondrial complex-1 were measured. In addition, oxidative stress and neuroinflammatory markers as well as caspase-3 expression were also evaluated besides histopathological examinations of different brain regions. Results: Treatment with Propolis and/or L-dopa ameliorated cognition and locomotor activity impairments induced by RT. Moreover, depletions in monoamines, mitochondrial complex-1 and elevations in AchE, caspase-3 expression oxidative as well as neuroinflammatory markers were also decreased. Histopathological examinations confirmed the pronounced effects obtained by combination of Propolis with low dose L-dopa than the higher used dose alone. Conclusion: Propolis is efficient in protection from PD development and represents a suitable adjuvant therapy that can be translated to marked reduction of the long-term treatment side effects by the mainstay therapy L-dopa. Consequently, Propolis could be recommended as a disease-modifying therapy of PD as well as a promising adjuvant therapy with L-dopa especially when given early in the treatment course.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Azza A Ali”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels